A Prospective Study on the Added Value of Pulsed Arterial Spin-Labeling and Apparent Diffusion Coefficients in the Grading of Gliomas

References

1. ↵
   Law M, Oh S, Babb JS, et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging—prediction of patient clinical response. Radiology 2006;238:658–67

   CrossRefPubMedWeb of Science
2. ↵
   Leon SP, Folkerth RD, Black P. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996;77:362–72

   CrossRefPubMedWeb of Science
3. ↵
   Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, et al. Microvessel density in brain tumors. Anticancer Res 1997;17:4747–53

   PubMed
4. ↵
   McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003;9:713–25

   CrossRefPubMedWeb of Science
5. ↵
   Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected] [published erratum appears in AJNR Am J Neuroradiol 2004;25:B1]. AJNR Am J Neuroradiol 2004;25:214–21

   Abstract/FREE Full Text
6. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98

   Abstract/FREE Full Text
7. ↵
   Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55

   Abstract/FREE Full Text
8. ↵
   Bhujwalla ZM, Artemov D, Natarajan K, et al. Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clin Cancer Res 2003;9:355–62

   Abstract/FREE Full Text
9. ↵
   Robinson SP, McIntyre DJ, Checklev D, et al. Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br J Cancer 2003;88:1592–97

   CrossRefPubMedWeb of Science
10. ↵
    Kiessling F, Krix M, Heilmann M, et al. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography. Invest Radiol 2003;38:516–24

    CrossRefPubMedWeb of Science
11. ↵
    Degani H, Chetrit-Dadiani M, Bogin L, et al. Magnetic resonance imaging of tumor vasculature. Thromb Haemost 2003;89:25–33

    PubMedWeb of Science
12. Li KL, Zhu XP, Checkley DR, et al. Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol 2003;76:39–50

    Abstract/FREE Full Text
13. Marzola P, Farace P, Calderan L, et al. In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure. Int J Cancer 2003;104:462–68

    CrossRefPubMedWeb of Science
14. ↵
    Rydland J, BjOrnerud A, Haugen O, et al. New intravascular contrast agent applied to dynamic contrast enhanced MR imaging of human breast cancer. Acta Radiol 2003;44:275–83

    CrossRefPubMedWeb of Science
15. ↵
    Bogin L, Margalit R, Mispelter J, et al. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers. J Magn Reson Imaging 2002;16:289–99

    CrossRefPubMed
16. ↵
    Rempp KA, Brix G, Wenz F, et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637–41

    PubMedWeb of Science
17. Calamante F, Thomas DL, Pell GS, et al. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab 1999;19:701–35

    CrossRefPubMedWeb of Science
18. ↵
    Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging 2001;13:496–520

    CrossRefPubMedWeb of Science
19. ↵
    Warmuth C, Günther M, Zimmer C. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 2003;228:523–32

    CrossRefPubMedWeb of Science
20. ↵
    Brunberg JA, Chenevert TL, McKeever PE, et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres [published erratum appears in AJNR Am J Neuroradiol 1995;16:1384]. AJNR Am J Neuroradiol 1995;16:361–71

    Abstract/FREE Full Text
21. ↵
    Castillo M, Smith JK, Kwock L, et al. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2001;22:60–64

    Abstract/FREE Full Text
22. ↵
    Kitis O, Altay H, Calli C, et al. Minimum apparent diffusion coefficients in the evaluation of brain tumors. Eur J Radiol 2005;55:393–400

    CrossRefPubMed
23. ↵
    Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22:1081–88

    Abstract/FREE Full Text
24. ↵
    Lam WW, Poon WS, Metreweli C. Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol 2002;57:219–25

    CrossRefPubMed
25. ↵
    Daumas-Duport C, Beuvon F, Varlet P, et al. [Gliomas: WHO and Sainte-Anne Hospital classifications]. Ann Pathol 2000;20:413–28

    PubMedWeb of Science
26. ↵
    Castillo M, Scatliff JH, Bouldin TW, et al. Radiologic-pathologic correlation: intracranial astrocytoma. AJNR Am J Neuroradiol 1992;13:1609–16

    FREE Full Text
27. Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology 1990;174:411–15

    CrossRefPubMedWeb of Science
28. ↵
    Tervonen O, Forbes G, Scheithauer BW, et al. Diffuse “fibrillary” astrocytomas: correlation of MRI features with histopathologic parameters and tumor grade. Neuroradiology 1992;34:173–78

    CrossRefPubMed
29. ↵
    Kelly PJ, Daumas-Duport C, Kispert DB, et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987;66:865–74

    CrossRefPubMedWeb of Science
30. ↵
    Burger PC. Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. Semin Oncol 1986;13:16–26

    PubMed
31. ↵
    Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 2000;174:1147–57

    PubMed
32. ↵
    Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98

    CrossRefPubMedWeb of Science
33. ↵
    Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29

    CrossRefPubMedWeb of Science
34. ↵
    Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479–86

    CrossRefPubMedWeb of Science
35. ↵
    Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

    PubMedWeb of Science
36. ↵
    Lev MH, Rosen BR. Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 1999;9:309–31

    PubMedWeb of Science
37. ↵
    Buxton RB, Frank LR, Wong EC, et al. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 1998;40:383–96

    CrossRefPubMedWeb of Science
38. ↵
    Tien RD, Felsberg GJ, Friedman H, et al. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 1994;162:671–77

    PubMedWeb of Science
39. ↵
    Noguchi K, Watanabe N, Nagayoshi T, et al. Role of diffusion-weighted echo-planar MRI in distinguishing between brain abscess and tumour: a preliminary report. Neuroradiology 1999;41:171–74

    CrossRefPubMed
40. ↵
    Levy LM. What is right about MRI permeability studies. AJNR Am J Neuroradiol 2005;26:3–4

    FREE Full Text